The purpose of the study is to assess the the effect of the study product on itching symptoms associated with xerotic dermatitis in aged population

Inclusion Criteria:

• Aged from 70 years
• With xerotic dermatitis, clinically assessed ,
• At least on the anterior part of lower and/or upper limbs,
• Presenting itching xerotic dermatitis evolving from at least 3 weeks
• Intensity of itching ≥ 4 on VAS (0-10) at th inclusion time
• With MMSE score ≥ 20 dating less than 6 months
• Affiliated to a social security system, or is a beneficiary (as applicable in the national regulation)

Exclusion Criteria:

• Criteria related to pathologies

  • Severe form of other dermatitis requiring either systemic treatment

    -- Itching xerotic dermatitis from iatrogenic origins

  • Dermatological disease other than xerotic dermatitis which could interfere with the assessment,

  • Systemic disease that may generate xerotic dermatitis and /or pruritus

  • Immunosuppression condition,

  • History of serious disease considered by the investigator hazardous for the patient or incompatible with the study.

• Criteria related to treatment

  - Use of treatment which could interfere with the evaluation of the disease or the course of the disease

• Criteria related to the population

  • Ongoing participation to another clinical trial or participation in the previous month before the inclusion
  • Patient under guardianship or trusteeship